Reliability of Six Prognostic Models to Predict Time-To-First-Treatment in Patients With Chronic Lymphocytic Leukaemia in Early Phase

American Journal of Hematology - United States
doi 10.1002/ajh.24707
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

The Prognostic Significance of Cytopenia in Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma

British Journal of Haematology
Hematology
2008English

CD38 Expression Is an Important Prognostic Marker in Chronic Lymphocytic Leukaemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Chronic Lymphocytic Leukaemia

Nature Reviews Disease Primers
Medicine
2017English

Efficancy of Rituximab With Chlorambucil Regimen in Elderly Patients With Chronic Lymphocytic Leukaemia

Hematology & blood transfusion: interdepartamental collection
2016English

A Phase II Trial of Eltrombopag for Patients With Chronic Lymphocytic Leukaemia (CLL) and Thrombocytopenia

British Journal of Haematology
Hematology
2018English

Idealisib Rapidly Improves Platelet Function Tests in Patients With Chronic Lymphocytic Leukaemia

British Journal of Haematology
Hematology
2018English

Bendamustine and Its Role in the Treatment of Unfit Patients With Chronic Lymphocytic Leukaemia: A Perspective Review

Therapeutic Advances in Hematology
Hematology
2017English

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2016English

Treatment Options for High-Risk Chronic Lymphocytic Leukaemia

Therapeutic Advances in Hematology
Hematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy